Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001785982-21-000006
Filing Date
2021-01-04
Accepted
2021-01-04 09:16:13
Documents
1
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 ownership.html 5  
1 ownership.xml 5 3124
  Complete submission text file 0001785982-21-000006.txt   4783
Mailing Address 189 WELLS AVE NEWTON MA 02459
Business Address
CONAWAY DALE H (Reporting) CIK: 0001261770 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-35027 | Film No.: 21500362

Mailing Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464
Business Address C/O BIOXYTRAN, INC. 233 NEEDHAM ST, SUITE 300 NEWTON MA 02464 617-494-1199
BIOXYTRAN, INC (Issuer) CIK: 0001445815 (see all company filings)

EIN.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations